Board
The Board of Directors of the Novo Nordisk Foundation has ten members, of which seven are elected under the Articles of Association and three are employee elected board members. The Board has adopted a competence profile that describes the preferred competencies of the Board.
Lars Rebien Sørensen
Chair
Lars Munch
Vice Chair
Christopher A. Voigt
Member
Jakob Müller
Member
Lars Fugger
Member
Liselotte Højgaard
Member
Mads Grøn
Member
Nana Bule Sejbæk
Member
Steen Riisgaard
Member
Stig Strøbæk
Member
Pelle Munk-Poulsen
Board Secretary & General Counsel & Senior Vice President, Legal
Our management
Mads Krogsgaard Thomsen
CEO, Professor, DVM, PhD, DSc
Søren Nedergaard
Chief Operating Officer
Steffen P. Lüders
Senior Vice President, Corporate Affairs
Claus Felby
Senior Vice President, Biotech, Professor, PhD
Lene Oddershede
Senior Vice President, Natural & Technical Sciences, Professor
Martin Ridderstråle
Senior Vice President, Chief Medical Officer, MD, PhD, MBA, Professor
Berith Bjørnholm
Senior Vice President, Education & Outreach, PhD
Peter Lawætz Andersen
Chief Scientific Advisor, Infectious Diseases, Professor, DVM, DSc
Arne Astrup
Senior Vice President, Obesity and Nutritional Sciences, professor, MD, DMSc
Thomas Alslev Christensen
Senior Vice President, Impact, PhD
Mikkel Skovborg
Senior Vice President, Innovation
Pelle Munk-Poulsen
Board Secretary & General Counsel & Senior Vice President, Legal
Flemming Konradsen
Senior Vice President, Social & Humanitarian , Professor
Stine Fehmerling
Senior Vice President, People & Organisation
Anne Kahr Hällman
Vice President, Grant Management, PhD
Sofie Singbrant Söderberg
Director, Head of Project & Portfolio Management, PhD
Andreas Hansen
Director, Head of Finance